Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-105200
Filing Date
2024-09-10
Accepted
2024-09-10 16:53:11
Documents
1
Period of Report
2024-09-09

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3909
  Complete submission text file 0000950170-24-105200.txt   5341
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Issuer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EFFECTOR THERAPEUTICS, INC. 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address
Warner Douglas J (Reporting) CIK: 0001941311 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40800 | Film No.: 241290626